UFPT Stock Analysis: Buy, Sell, or Hold?
UFPT - UFP Technologies Inc
$236.17
2.86 (1.23%)
▲
5d:
+1.07%
30d:
+4.45%
90d:
+25.11%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When UFPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: UFPT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: UFPT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$350.25
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$217.48
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UFPT is currently trading at $236.16, which is considered extended relative to its 30-day fair value range of $219.82 to $233.95. The stock's valuation (Forward PE: 20.0) is in line with its historical norms (20.2). Remarkably, the market is currently pricing in an annual earnings decline of 0.4% over the next few years. This pessimistic expectation contrasts with the company's recent 1.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, UFPT is showing sideways momentum. Immediate support is located at $223.87, while resistance sits at $243.68.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $324.50 (+39.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, UFPT is showing sideways momentum. Immediate support is located at $223.87, while resistance sits at $243.68.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $324.50 (+39.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$219.82 -
$233.95
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.0%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.1% below Wall St target ($324.50)
Trading Range Analysis
30-Day Trading Range
$219.82 -
$233.95
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$223.87
Resistance Level
$243.68
Current Trend
Sideways
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.96
Wall Street Target
$324.50
(+39.1%)
Revenue Growth (YoY)
4.1%
Earnings Growth (YoY)
1.4%
Profit Margin
11.3%
Valuation Discount vs History
-0.4% cheaper
PE vs Historical
20.0 vs 20.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.4%
(market-implied from PE analysis)
1-Year Target
$232.37
(0%)
2-Year Target
$231.44
(-1%)
3-Year Target
$230.51
(-1%)
3-Yr Target (if PE normalizes)
(PE: 20→20)
$233.27
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 12.5%)
$362.85
(+56%)
Base:
(SPY PE: 20.0, Growth: 12.5%)
$332.55
(+43%)
Bear:
(PE: 17.0, Growth: 12.5%)
$282.67
(+21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 27.25 | Current EPS (TTM): $8.78
Bull Case
$350.37
(+50%)
Analyst growth 33.1%, PE expands to 30.0
Base Case
$318.52
(+37%)
Market implied 33.1%, PE stable at 27.3
Bear Case
$162.71
(-30%)
Severe decline -20.0%, PE contracts to 23.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.0 to 20.2
Stabilization Target:
$236.09
(+1.2%)
PE Expansion Potential:
+1.2%
Share & Embed Analysis
Last updated: June 23, 2026 2:32 PM ET
Data refreshes hourly during market hours. Next update: 3:32 PM
Data refreshes hourly during market hours. Next update: 3:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UFPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 61 BUY |
